Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

15.35
Delayed Data
As of Aug 04
 -0.50 / -3.15%
Today’s Change
2.50
Today|||52-Week Range
30.13
+91.64%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close15.85
Today’s open15.89
Day’s range14.97 - 16.23
Volume664,706
Average volume (3 months)1,483,100
Market cap$523.1M
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+76.34%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales54.40
Price/Book15.85

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.10-2.53%
CORTCorcept Therapeutics...+0.09+1.89%
AFMDAffimed NV-0.94-5.85%
ASNDAscendis Pharma A/S+0.17+0.87%
Data as of 3:59pm ET, 08/04/2015

Financials

Next reporting dateSeptember 30, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$1.0M
Annual profit (last year)-$16.5M
Net profit margin-1,652.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, EVP &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts